British International Investment
MedAccess was founded by British International Investment (BII), the UK’s development finance institution, in 2017.
BII is our anchor investor, with $170 million paid-in capital which is used to shape agreements that break down barriers stopping people from accessing medical innovations.
BII is MedAccess’ sole shareholder. However, any operating surpluses are invested into developing new agreements to accelerate access to healthcare.
UK Foreign, Commonwealth & Development Office
Since 2021, the UK’s Foreign, Commonwealth & Development Office (FCDO) has provided MedAccess with £17 million in grant funding as part of its Global Fund Accelerator programme. FCDO’s support has enabled us to construct and execute volume guarantee agreements that have secured lower prices and sustainable supply for products procured by countries supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. This has also unlocked additional value for FCDO’s £1 billion investment in the Global Fund.
Thanks to this partnership, healthcare workers can test for HIV and syphilis in a single rapid test, people with latent TB can take a new regimen that is shorter and more effective than the previous standard of care, and patients can be tested for an enzyme deficiency to inform appropriate treatment for P. vivax malaria.
Gates Foundation
In 2023, the Gates Foundation awarded MedAccess a grant of $2.5 million to explore opportunities to stabilise the market for micronutrients used in large-scale food fortification. Globally, more than two billion people lack regular access to nutritious and sufficient food and suffer from micronutrient malnutrition. By fortifying foods with vitamins, minerals or micronutrients, populations can expect greater health outcomes.
Using the grant, MedAccess is evaluating the market with a view to structuring a potential volume guarantee agreement that can help increase micronutrient supply reliability and price stability in low- and middle-income countries.
European Investment Bank
In 2025, the European Investment Bank (EIB) announced a Guarantee Agreement for MedAccess worth up to €52 million.
The agreement is one of the first operations under the Human Development Accelerator (HDX), a joint program between the European Commission, the EIB and the Gates Foundation, to accelerate investment opportunities that enable greater access to and affordability of health products in low- and middle-income countries. It fully aligns with the European Union’s Global Gateway Strategy.
The EIB’s guarantee agreement will enable MedAccess to pursue more volume guarantees for the health sector in Africa by providing a counter-guarantee covering up to 30% of losses that MedAccess may incur on eligible volume guarantees.
Wellcome
In 2025, Wellcome provided MedAccess with a $450,000 grant to scope opportunities use innovative finance and market shaping tools to increase access to products for mental health conditions.
Mental health conditions are a growing challenge in low- and middle-income countries, where they account for a substantial share of disability and premature mortality. Yet more than 75% of people living with a mental health condition in these countries receive no treatment at all, due to systemic underfunding, scarce specialist workers and the limited availability and affordability of essential psychotropic medicines.
MedAccess will conduct detailed research on treatments for four mental health conditions, including psychosis. We will consult with physicians, manufacturers and public health experts to assess where innovative finance could help unlock access and to inform future efforts.
MedAccess Trust
MedAccess Trust was established in 2021 to receive and provide stewardship for grants from funders seeking to increase access to healthcare in low- and middle-income countries.
The Trust shares MedAccess’ vision and mission to speed up access to lifesaving vaccines, medicines, diagnostics and technologies to prevent illness, disease and deaths.
MedAccess Trust is overseen by independent trustees with absolute discretion in advancing its purposes. The trustees have power to make grants to any organisation, including MedAccess, that aligns with its aim of increasing access to healthcare.
Support MedAccess
We are unrelenting in our mission to achieve more impact and reach more people with lifesaving medical products. MedAccess’ donors and investors have a demonstrable impact on human health by ensuring affordable products reach the people who need them at scale.
If you are interested in finding out more, please get in touch.
